Pacira reported $757.77M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Astellas Pharma JPY 1.48T 31.46B Jun/2025
Bristol-Myers Squibb USD 17.49B 100M Jun/2025
Ironwood Pharmaceuticals USD -301245000 10.09M Dec/2024
J&J USD 78.11B 6.62B Mar/2025
Ligand Pharmaceuticals USD 828.53M 32.99M Jun/2025
Novo Nordisk 168.07B 29.53B Jun/2025
Pacira USD 757.77M 40.77M Jun/2025
Perrigo USD 4.47B 108.3M Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
Supernus Pharmaceuticals USD 1.06B 33.2M Jun/2025
Teva Pharmaceutical Industries USD 6.83B 572M Jun/2025
Xeris Pharmaceuticals USD -19300000 10.32M Jun/2025
Zoetis USD 4.98B 322M Jun/2025